A- A A+

Benzodiazepines.

Bounds CG, Nelson VL.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Nov 26.

https://www.ncbi.nlm.nih.gov/books/NBK470159/

Benzodiazepine drug use and cancer risk: a dose-response meta analysis of prospective cohort studies.

Zhang T, Yang X, Zhou J, Liu P, Wang H, Li A, Zhou Y.

Oncotarget. 2017 Oct 19;8(60):102381-102391. doi: 10.18632/oncotarget.22057.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731963/

Benzodiazepines and risk of all cause mortality in adults: cohort study.

Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF.

BMJ. 2017 Jul 6;358:j2941. doi: 10.1136/bmj.j2941.

http://www.bmj.com/content/358/bmj.j2941

Benzodiazepine maintenance for alcohol dependence: A case series.

Kattimani S, Bharadwaj B, Arun AB.

J Family Med Prim Care. 2017 Apr-Jun;6(2):431-433. doi: 10.4103/2249-4863.220038.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749099/

Empfehlung zur ärztlichen Verordnung von Benzodiazepinen

Sucht- und Drogenkoordination Wien, 2017

https://sdw.wien/wp-content/uploads/Empfehlung-zur-%C3%A4rztlichen-Verordnung-von-Benzodiazepinen_low_res_fin.pdf

Is misuse of benzodiazepines among high-risk drug users an overlooked public health issue?

Dominique Lopez, Lisbon Addictions 2017, Second European Conference on Addictive Behaviours and Dependencies, Lissabon, 24.-26.10.2017

http://www.emcdda.europa.eu/system/files/attachments/6815/12H45_2_Dominique Lopez.pptx

Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.

Stein MD, Anderson BJ, Kenney SR, Bailey GL.

J Subst Abuse Treat. 2017 Jun;77:67-71. doi: 10.1016/j.jsat.2017.03.002.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/28476275

Evaluating the impact of prescribed versus non-prescribed benzodiazepine use in opioid substitution therapy: Results from a population-based retrospective cohort study

Joseph K. Eibl, Lisbon Addictions 2017, Second European Conference on Addictive Behaviours and Dependencies, Lissabon, 24.-26.10.2017

http://www.emcdda.europa.eu/system/files/attachments/6779/11H30_5_Joseph Eibl.pptx

High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City

Mateu-Gelabert, Pedro et al.

International Journal of Drug Policy , Volume 46 , 17 - 27

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/28577506

Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates

Vivek Pillai, PhD, Thomas Roth, PhD, Timothy Roehrs, PhD, Kenneth Moss, MD, Edward L. Peterson, PhD, Christopher L. Drake, PhD;

Sleep, Volume 40, Issue 2, 1 February 2017, zsw044, org/10.1093/sleep/zsw044

https://academic.oup.com/sleep/article-lookup/doi/10.1093/sleep/zsw044

CME. Concurrent Opioid, Benzodiazepine Use Ups Overdose Risk

Authors: News Author: Caroline Cassels; CME Author: Charles P. Vega, MD;

CME / ABIM MOC / CE Released: 4/26/2017

Valid for credit through: 4/26/2018

http://www.medscape.org/viewarticle/877585

Based on our additional review, the U.S. Food and Drug Administration (FDA) is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system (CNS). The combined use of these drugs increases the risk of serious side effects; however, the harm caused by untreated opioid addiction can outweigh these risks. Careful medication management by health care professionals can reduce these risks. We are requiring this information to be added to the buprenorphine and methadone drug labels along with detailed recommendations for minimizing the use of medication-assisted treatment (MAT) drugs and benzodiazepines together. (FDA – U.S. Food&Drug Administration, 20.09.2017)

https://www.fda.gov/Drugs/DrugSafety/ucm575307.htm

Benzodiazepine absetzen im Alter - Wann und, wenn ja, wie?

Dr. Dirk K. Wolter

Zeitschrift für Gerontologie und Geriatrie  Ausgabe 2/2017

Abstract

https://www.springermedizin.de/der-geriatrische-patient/geriatrie-und-gerontologie/benzodiazepine-absetzen-im-alter/12007814

(...) Today, the FDA issued a Drug Safety Communication alerting health care providers and patients of the increased risk of serious side effects when combining these particular MAT drugs with benzodiazepines – often prescribed to treat anxiety, insomnia, or other conditions – and how to address these risks while continuing to maintain patients on MAT. (FDA – U.S. Food&Drug Administration, 20.09.2017)

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm576752.htm

The Emergence of New Psychoactive Substance (NPS) Benzodiazepines: A Review.

Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD.

Drug Test Anal. 2017 May 4. doi: 10.1002/dta.2211.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/28471096

"I love having benzos after my coke shot": The use of psychotropic medication among cocaine users in downtown Montreal.

Motta-Ochoa R, Bertrand K, Arruda N, Jutras-Aswad D, Roy É.

Int J Drug Policy. 2017 Aug 18;49:15-23. doi: 10.1016/j.drugpo.2017.07.012.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/28826127